A hemodialysis patient with acquired factor V inhibitor who developed cerebral hemorrhage: A case report-Reference-Cited by-同舟云学术

A hemodialysis patient with acquired factor V inhibitor who developed cerebral hemorrhage: A case report

Published:2023 Issue:1 Volume:56 Page:29-36
ISSN:1340-3451
Container-title:Nihon Toseki Igakkai Zasshi
language:en
Short-container-title:Nihon Toseki Igakkai Zasshi

Author:

Ishisaka Mana¹,Endo Syunsuke¹,Tamai Akira¹,Kurata Tazuko¹,Terasaki Yasushi²,Oota Satoshi¹,Ishida Youichi¹,Asakura Hidesaku³,Ieko Masahiro⁴,Ichinose Akitada³

Affiliation:

1. Department of Nephrology, Toyama City Hospital

2. Department of Hematology, Toyama City Hospital

3. The Japanese Collaborative Research Group (JCRG) on Autoimmune Acquired Coagulation Factor Deficiencies supported by the Japanese Ministry of Health, Labour and Welfare (MHLW)

4. Department of Hematology, Iwate Prefectural Chubu Hospital

Publisher

Japanese Society for Dialysis Therapy

Subject

Organic Chemistry,Biochemistry

Link

https://www.jstage.jst.go.jp/article/jsdt/56/1/56_29/_pdf

Reference28 articles.

1. 1) 山田真也，朝倉英策．後天性第V因子インヒビター．臨床血液 2020；61：791-8．

2. 2) Ichinose A, Osaki T, Souri M. A Review of Coagulation Abnormalities of Autoimmune Acquired Factor V Deficiency with a Focus on Japan. Semin Thromb Hemost 2022；48：206-18.

3. 3) Chartier AR, Hillert CJ, Gill H, Jha P. Acquired Factor V Inhibitor After Antibiotic Therapy：A Clinical Case Report and Review of the Literature. Cureus 2020；12：e9481.

4. 4) Franchini M, Lippi G. Acquired factor V inhibitors: a systematic review. J Thromb Thrombolysis 2011； 31：449-57.

5. 5) Sakatoku K, Takakuwa T, Miura A, Araki T, Fujitani Y, Yamamura R. Acquired Factor V Inhibitor with Hemorrhagic Symptoms after Prasugrel Hydrochloride Treatment. Acta Haematol 2020；143：478-80.